Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INBS
INBS logo

INBS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Intelligent Bio Solutions Inc (INBS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.990
1 Day change
12.41%
52 Week Range
24.900
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Intelligent Bio Solutions Inc (INBS) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock shows mixed technical signals, lacks significant positive catalysts, and has weak financial performance despite revenue growth. Given the absence of strong trading signals or positive sentiment, it is better to hold off on investing in this stock for now.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 44.362, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.662, with resistance at 2.854 and support at 2.469. Overall, the technical indicators suggest a mixed trend with no clear buy signal.

Positive Catalysts

  • Revenue increased by 47.62% YoY in Q2 2026, indicating some growth potential.

Neutral/Negative Catalysts

  • Net income remains negative at -2.68M, EPS dropped by -43.15% YoY, and gross margin decreased significantly to 19.83%, showing poor profitability. No recent news or significant trading trends from insiders or hedge funds.

Financial Performance

In Q2 2026, revenue grew by 47.62% YoY to $896,774. However, net income remains negative at -$2,677,590 (up 19.03% YoY), EPS dropped to -2.82 (down 43.15% YoY), and gross margin fell to 19.83% (down 246.78% YoY). The financials indicate revenue growth but poor profitability and declining margins.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Wall Street analysts forecast INBS stock price to rise
Analyst Rating
0
Wall Street analysts forecast INBS stock price to rise
Buy
Hold
Sell
0
Current: 2.660
sliders
Low
0
Averages
0
High
0
0
Current: 2.660
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch